Roundup on trial: Law firms spent $91 million in one year to recruit plaintiffs for glyphosate-cancer suits

Print Friendly, PDF & Email

In 2019, an estimated $91 million was spent on ads seeking clients to pursue Roundup-related claims, making it the No. 1 product to be featured in TV advertising, according to X Ante, citing data from ad-tracking firm Kantar CMAG.

By contrast, only $23 million was spent on Roundup ads in 2020. Roundup ranked third for most-featured product, behind the heartburn drug Zantac and talcum powder, for which an estimated $37.9 million and $34.8 million were spent, respectively.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

The decline in Roundup ad spending came as Bayer in June agreed to a $10.9 billion proposed settlement to resolve tens of thousands of lawsuits and claims alleging Roundup and its active ingredient glyphosate cause cancer. It denies the allegations.

Read the original post

Related article:  Mexico 2024 glyphosate ban put on hold after Bayer successfully challenges presidential decree
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists